1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The population of the Netherlands was 16.8 million in 2013, having grown at a Compound Annual Growth Rate (CAGR) of 0.5% from 2008. The country’s increasingly elderly population and a corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical market, which was estimated to be worth $6.7 billion in 2013 and is projected to reach $7.1 billion in 2020. The medical device market was valued at $3.2 billion in 2013, having grown at a CAGR of 4.1% from $2.6 billion in 2008.

These growth trends can be primarily attributed to -
- The country’s increasingly elderly population
- The state’s universal health coverage
- An increase in hospital expenditure on expensive medicines (medicines priced above €500 ($670.4)

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Netherlands, including -
- An overview of the pharmaceutical and medical device markets, covering market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Abbott, AstraZeneca, GlaxoSmithKline and Merck; and profiles and SWOT analyses of the major players in the medical device market: Medtronic, Siemens Healthcare, F.Hoffmann-La Roche, DePuy and Essilor International
- An insightful review of the reimbursement and regulatory landscape, with analysis covering the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in the Netherlands’ healthcare market

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands
1 Table of Contents

2 Introduction 20
2.1 GlobalData Report Guidance 20
3 Overview of Pharmaceutical and Medical Device Markets 21
3.1 Pharmaceutical Market 21
3.1.1 Market Overview 21
3.1.2 Pharmaceutical Exports and Imports 24
3.1.3 Supply Channels 26
3.1.4 Market Segments 27
3.1.5 Major Therapeutic Areas 30
3.1.6 Major Players 33
3.2 Medical Device Market 73
3.2.1 Market Overview 73
3.2.2 Overview of Top Five Segments 75
3.2.3 Diagnostic Market 89
3.2.4 Major Players 90
3.3 Market Drivers and Barriers 122
3.3.1 Drivers 122
3.3.2 Barriers 124
4 Market Access 126
4.1 Reimbursement and Payer Landscape 126
4.1.1 Overview of Healthcare System 126
4.1.2 Reimbursement Process 127
4.1.3 Overview of Insurance Providers 130
4.1.4 Patients Share in Healthcare Spending 133
4.1.5 Healthcare Price Trends 134
4.1.6 Pricing Policies 135
4.2 Regulatory Landscape 136
4.2.1 Overview of Regulatory Agencies 136
4.2.2 Market Authorization Procedure for Pharmaceutical Products 138
4.2.3 New Medical Device Approval Process 146
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 151
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 152
4.2.6 Intellectual Property Rights 153
4.2.7 Clinical Trial Regulation 155
4.2.8 Pharmaceutical Advertising Regulations 156
4.2.9 Pharmacy Regulations 157
4.2.10 Labeling and Packaging Regulations 157
5 Country Analysis 159
5.1 Political Environment 159
5.1.1 Political Structure 159
5.1.2 Analysis of the Current Political Environment 160
5.1.3 Healthcare Policy Initiatives 161
5.2 Economic Landscape 163
5.3 Economic Indicators 165
5.3.1 Gross Domestic Product 165
5.3.2 Gross National Income 170
5.3.3 Inflation 171
5.3.4 Currency Exchange Rate 174
5.3.5 Foreign Direct Investment 176
5.3.6 Foreign Exchange Reserves 177
5.3.7 Trade Balance 178
5.3.8 General Government Structural Balance 181
5.3.9 General Government Gross Debt 182
5.3.10 Major Industries 184
5.4 Demographics 186
5.4.1 Population 186
5.4.2 Education and Literacy 205
5.4.3 Employment 207
5.4.4 Disease Burden 209
5.5 Healthcare Infrastructure 212
5.5.1 Healthcare Facilities 212
5.5.2 Healthcare Parameters 216
5.5.3 Environmental Health 219
5.5.4 Healthcare Personnel 226
5.6 Healthcare Expenditures 230
5.6.1 Overview 230
5.6.2 Major Components of Healthcare Spending 231
5.6.3 Share of Public and Private Sectors 233
5.6.4 Spending in Pharmaceutical and Healthcare RandD 234
5.7 Trade Associations 235
5.7.1 Nefemed 235
5.7.2 Nefarma 235
5.7.3 Neprofarm 235
5.7.4 Diagned 236
5.8 Trade Fairs 236
6 Opportunities and Challenges 238
6.1 Opportunities 238
6.2 Challenges 239
7 Appendix 241
7.1 Abbreviations 241
7.2 Bibliography 248
7.3 Research Methodology 263
7.3.1 Coverage 264
7.3.2 Secondary Research 264
7.3.3 Forecasts 265
7.3.4 Expert Panel 265
7.4 Disclaimer 265

1.1 List of Tables

Table 1: Pharmaceutical Market, Netherlands, Revenue ($bn), 2008-2013 23
Table 2: Pharmaceutical Market, Netherlands, Revenue Forecast ($bn), 2014-2020 24
Table 3: Pharmaceutical Market, Netherlands, Exports and Imports ($bn), 2008-2013 25
Table 4: Pharmaceutical Market, Netherlands, Price Margins of Distribution Channel (%), 2011 27
Table 5: Pharmaceutical Market, Netherlands, OTC Drugs Market Revenue ($m), 2008-2013 29
Table 6: Pharmaceutical Market, Netherlands, Major OTC Drug Class Revenue ($m) and Market Share (%), 2013 30
Table 7: Pharmaceutical Market, Pfizer, Global, Major Products, 2013 34
Table 8: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014 35
Table 9: Pharmaceutical Market, AstraZeneca, Global, Major Products by Therapy Area, Revenue ($bn) and Annual Growth (%), 2013 50
Table 10: Pharmaceutical Market, AstraZeneca, Global, Late-stage Pipeline*, 2014 51
Table 11: Pharmaceutical Market, GlaxoSmithKline, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 58
Table 12: Pharmaceutical Market, GlaxoSmithKline, Global, Late-Stage Pipeline, 2014 59
Table 13: Pharmaceutical Market, Merck, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 66
Table 14: Pharmaceutical Market, Merck, Global, Late-Stage Pipeline, 2014 67
Table 15: Medical Device Market, Netherlands, Revenue ($bn), 2008-2013 74
Table 16: Medical Device Market, Netherlands, Revenue Forecast ($bn), 2014-2020 75
Table 17: Medical Device Market, Netherlands, Segments, 2013 76
Table 18: Medical Device Market, Netherlands, Cardiovascular Devices Market Revenue ($m), 2008-2013 77
Table 19: Medical Device Market, Netherlands, Cardiovascular Devices Market, Sales Trends for Major Players, 2012 78
Table 20: Medical Device Market, Netherlands, Ophthalmic Devices Market Revenue ($m), 2008-2013 79
Table 21: Medical Device Market, Netherlands, Ophthalmic Devices Market, Sales Trends for Major Players, 2012 81
Table 22: Medical Device Market, Netherlands, In Vitro Diagnostics Market Revenue ($m), 2008-2013 82
Table 23: Medical Device Market, Netherlands, In Vitro Diagnostics Market, Sales Trends for Major Players, 2012 83
Table 24: Medical Device Market, Netherlands, Orthopedic Devices Market Revenue ($m), 2008-2013 84
Table 25: Medical Device Market, Netherlands, Orthopedic Devices Market, Sales Trends for Major Players, 2012 86
Table 26: Medical Device Market, Netherlands, Hospital Supplies Market Revenue ($m), 2008-2013 87
Table 27: Medical Device Market, Netherlands, Hospital Supplies Market, Sales Trends for Major Players, 2012 88
Table 28: Medical Device Market, Netherlands, Diagnostic Market, Revenue ($m), 2008-2013 89
Table 29: Medical Device Market, Netherlands, Diagnostic Market, Revenue Forecast ($m), 2014-2020 90
Table 30: Medical Device Market, Netherlands, Major Medical Device Companies, Revenue, 2012 91
Table 31: Medical Device Market, Medtronic, Global, Major Products, 2013 93
Table 32: Medical Device Market, F. Hoffmann-La Roche, Global, Major Products, 2014 106
Table 33: Market Access, Netherlands, Drug Reimbursement Categories, 2014 129
Table 34: Market Access, Netherlands, Major Health Insurers, Market Share (%), 2014 133
Table 35: Healthcare Spending, Netherlands, Out-of-Pocket Expenditure (%), 2008-2013 134
Table 36: Market Access, Netherlands, Consumer Price Index Annual Change (%), 2008-2013 135
Table 37: Economic Indicators, Netherlands, GDP per Capita ($), 2008-2013 167
Table 38: Economic Indicators, Netherlands, GDP per Capita Forecast ($), 2014-2020 167
Table 39: Economic Indicators, Netherlands, GDP Annual Growth (%), 2008-2013 168
Table 40: Economic Indicators, Netherlands, GDP Annual Growth Forecast (%), 2014-2020 169
Table 41: Economic Indicators, Netherlands, Gross National Income per Capita ($), 2008-2013 171
Table 42: Economic Indicators, Netherlands, Average Consumer Price Index, 2008-2013 172
Table 43: Economic Indicators, Netherlands, Average Consumer Price Index Forecast, 2014-2020 173
Table 44: Economic Indicators, Netherlands, Average Consumer Price Annual Change (%), 2008-2013 174
Table 45: Economic Indicators, Netherlands, Currency Exchange Rate (€/$), 2008-2013 175
Table 46: Economic Indicators, Netherlands, Foreign Direct Investment ($bn), 2008-2013 177
Table 47: Economic Indicators, Netherlands, Foreign Exchange Reserves ($bn), 2008-2013 178
Table 48: Economic Indicators, Netherlands, Imports of Goods and Services ($bn), 2008-2013 179
Table 49: Economic Indicators, Netherlands, Exports of Goods and Services ($bn), 2008-2013 181
Table 50: Economic Indicators, Netherlands, Government Structural Balance ($bn), 2008-2013 182
Table 51: Economic Indicators, Netherlands, General Government Gross Debt (% of GDP), 2008-2013 183
Table 52: Economic Indicators, Netherlands, General Government Gross Debt Forecast (% of GDP), 2014-2020 184
Table 53: Economic Indicators, Netherlands, Major Industries, Output ($bn), 2012 186
Table 54: Demographics, Netherlands, Population (million), 2008-2013 187
Table 55: Demographics, Netherlands, Population Forecast (million), 2014-2020 188
Table 56: Demographics, Netherlands, Population, Urban and Rural Population (%), 2008-2013 189
Table 57: Demographics, Netherlands, Population, Urban and Rural Population Forecast (%), 2014-2020 190
Table 58: Demographics, Netherlands, Population Distribution by Age Group (%), 2008-2013 192
Table 59: Demographics, Netherlands, Population Distribution by Age Group Forecast (%), 2014-2020 193
Table 60: Demographics, Netherlands, Births (per 1,000 Population), 2008-2013 195
Table 61: Demographics, Netherlands, Mortality (per 1,000 Population), 2008-2013 196
Table 62: Demographics, Netherlands, Major Causes of Mortality (‘000), 2012 197
Table 63: Demographics, Netherlands, Children ?5 Years, Mortality Rate (per 1,000 Live Births), 2008-2013 198
Table 64: Demographics, Netherlands, Immunization Rate (%), 2008-2013 199
Table 65: Demographics, Netherlands, Major Causes of Male Mortality (‘000), 2012 200
Table 66: Demographics, Netherlands, Major Causes of Female Mortality (‘000), 2012 202
Table 67: Demographics, Netherlands, Gender Ratio (M/F), 2008-2013 203
Table 68: Demographics, Netherlands, Life Expectancy at Birth (Years), 2008-2013 205
Table 69: Demographics, Netherlands, Student Enrollment by Level of Education (‘000), 2011 206
Table 70: Demographics, Netherlands, Unemployment Rate (%), 2008-2013 207
Table 71: Demographics, Netherlands, Employment by Sector (%), 2012 208
Table 72: Demographics, Netherlands, Major Causes of Hospitalization (per 10,000 population), 2011 210
Table 73: Demographics, Netherlands, Major Diseases, DALYs (per 100,000 Population), 2004 211
Table 74: Healthcare Infrastructure, Netherlands, Hospitals, 2008-2013 213
Table 75: Healthcare Infrastructure, Netherlands, Hospital Beds (‘000), 2008-2013 214
Table 76: Healthcare Infrastructure, Netherlands, Diagnostic Equipment (per 1,000,000 Population), 2008-2013 215
Table 77: Healthcare Infrastructure, Netherlands, Hospital Beds (per 1,000 Population), 2008-2013 216
Table 78: Healthcare Infrastructure, Netherlands, Acute Care Hospital Beds (per 1,000 Population), 2008-2013 217
Table 79: Healthcare Infrastructure, Netherlands, Psychiatric Hospital Beds (per 1,000 Population), 2008-2013 218
Table 80: Healthcare Infrastructure, Netherlands, Doctors (per 1,000 Population), 2008-2013 219
Table 81: Healthcare Infrastructure, Netherlands, CO2 Emissions (Billion kg), 2008-2013 221
Table 82: Healthcare Infrastructure, Netherlands, PM10 Emissions (Million kg), 2008-2013 222
Table 83: Healthcare Infrastructure, Netherlands, SO2 Emissions (Million kg), 2008-2013 223
Table 84: Healthcare Infrastructure, Netherlands, Biochemical Oxygen Demand (mg/l), 2008-2013 224
Table 85: Healthcare Infrastructure, Netherlands, Municipal Waste per Capita (kg), 2008-2013 225
Table 86: Healthcare Infrastructure, Netherlands, Waste Handling (%), 2012 226
Table 87: Healthcare Infrastructure, Netherlands, Nurses (per 1,000 Population), 2008-2013 227
Table 88: Healthcare Infrastructure, Netherlands, Pharmacists (per 1,000 Population), 2008-2013 228
Table 89: Healthcare Infrastructure, Netherlands, Dentists (per 1,000 Population), 2008-2013 229
Table 90: Healthcare Expenditure, Netherlands, Healthcare Expenditure (% of GDP), 2008-2013 231
Table 91: Healthcare Expenditure, Netherlands, Share of Components (%), 2012 232
Table 92: Healthcare Expenditure, Netherlands, Public-Private Share (%), 2008-2013 234
Table 93: Healthcare Expenditure, Netherlands, RandD Expenditure by Type of Institution (% of GDP), 2011 235

1.2 List of Figures
Figure 1: Pharmaceutical Market, Netherlands, Revenue ($bn), 2008-2013 23
Figure 2: Pharmaceutical Market, Netherlands, Revenue Forecast ($bn), 2014-2020 24
Figure 3: Pharmaceutical Market, Netherlands, Exports and Imports ($bn), 2008-2013 25
Figure 4: Pharmaceutical Market, Netherlands, Distribution Channels, 2012 26
Figure 5: Pharmaceutical Market, Netherlands, OTC Drugs Market Revenue ($m), 2008-2013 29
Figure 6: Pharmaceutical Market, Netherlands, Major OTC Drug Class Market Share (%), 2013 30
Figure 7: Medical Device Market, Netherlands, Revenue ($bn), 2008-2013 73
Figure 8: Medical Device Market, Netherlands, Revenue Forecast ($bn), 2014-2020 74
Figure 9: Medical Device Market, Netherlands, Revenue by Segment ($m), 2013 75
Figure 10: Medical Device Market, Netherlands, Cardiovascular Devices Market Revenue ($m), 2008-2013 77
Figure 11: Medical Device Market, Netherlands, Cardiovascular Devices Market, Sales Trends for Major Players, 2008-2012 78
Figure 12: Medical Device Market, Netherlands, Ophthalmic Devices Market Revenue ($m), 2008-2013 79
Figure 13: Medical Device Market, Netherlands, Ophthalmic Devices Market, Sales Trends for Major Players, 2008-2012 80
Figure 14: Medical Device Market, Netherlands, In Vitro Diagnostics Market Revenue ($m), 2008-2013 82
Figure 15: Medical Device Market, Netherlands, In Vitro Diagnostics Market, Sales Trends for Major Players, 2008-2012 83
Figure 16: Medical Device Market, Netherlands, Orthopedic Devices Market Revenue ($m), 2008-2013 84
Figure 17: Medical Device Market, Netherlands, Orthopedic Devices Market, Sales Trends for Major Players, 2008-2012 85
Figure 18: Medical Device Market, Netherlands, Hospital Supplies Market Revenue ($m), 2008-2013 87
Figure 19: Medical Device Market, Netherlands, Diagnostic Market, Revenue ($m), 2008-2013 89
Figure 20: Medical Device Market, Netherlands, Diagnostic Market, Revenue Forecast ($m), 2014-2020 90
Figure 21: Medical Device Market, Netherlands, Major Medical Device Companies, Revenue ($m), 2012 91
Figure 22: Healthcare Market, Netherlands, Drivers and Barriers, 2014 125
Figure 23: Market Access, Netherlands, Organizational Structure of Healthcare System, 2014 127
Figure 24: Market Access, Netherlands, Drug Reimbursement Process, 2014 128
Figure 25: Market Access, Netherlands, Structure of Health Insurance, 2014 130
Figure 26: Market Access, Netherlands, Market Share (%), 2014 132
Figure 27: Healthcare Spending, Netherlands, Out-of-Pocket Expenditure (%), 2008-2013 134
Figure 28: Market Access, Netherlands, Consumer Price Index Annual Change (%), 2008-2013 135
Figure 29: Market Access, Netherlands, Organizational Structure of the Medicines Evaluation Board (MEB), 2014 137
Figure 30: Market Authorization, Netherlands, National Procedure for Market Authorization, 2014 139
Figure 31: Market Authorization, Netherlands, Centralized Process: Pre-submission Phase, 2014 141
Figure 32: Market Authorization, Netherlands, Centralized Process: Pre-opinion Phase, 2014 143
Figure 33: Market Authorization, Netherlands, Centralized Process: Post-opinion Phase, 2014 144
Figure 34: Market Authorization, Netherlands, Decentralized Procedure, 2014 145
Figure 35: Market Authorization, Netherlands, Mutual Recognition Procedure, 2014 146
Figure 36: Market Authorization, Netherlands, Conformity Assessment of Class I Medical Devices, EU, 2014 148
Figure 37: Market Authorization, Netherlands, Conformity Assessment of Class IIa Medical Devices, EU, 2014 149
Figure 38: Market Authorization, Netherlands, Conformity Assessment of Class IIb Medical Devices, EU, 2014 150
Figure 39: Market Authorization, Netherlands, Conformity Assessment of Class III Medical Devices, EU, 2014 151
Figure 40: Economic Indicators, Netherlands, GDP per Capita ($), 2008-2013 166
Figure 41: Economic Indicators, Netherlands, GDP per Capita Forecast ($), 2014-2020 167
Figure 42: Economic Indicators, Netherlands, GDP Annual Growth (%), 2008-2013 168
Figure 43: Economic Indicators, Netherlands, GDP Annual Growth Forecast (%), 2014-2020 169
Figure 44: Economic Indicators, Netherlands, Gross National Income per Capita ($), 2008-2013 170
Figure 45: Economic Indicators, Netherlands, Average Consumer Price Index, 2008-2013 172
Figure 46: Economic Indicators, Netherlands, Average Consumer Price Index Forecast, 2014-2020 173
Figure 47: Economic Indicators, Netherlands, Average Consumer Price Annual Change (%), 2008-2013 174
Figure 48: Economic Indicators, Netherlands, Currency Exchange Rate (€/$), 2008-2013 175
Figure 49: Economic Indicators, Netherlands, Foreign Direct Investment ($bn), 2008-2013 176
Figure 50: Economic Indicators, Netherlands, Foreign Exchange Reserves ($bn), 2008-2013 177
Figure 51: Economic Indicators, Netherlands, Imports of Goods and Services ($bn), 2008-2013 179
Figure 52: Economic Indicators, Netherlands, Exports of Goods and Services ($bn), 2008-2013 180
Figure 53: Economic Indicators, Netherlands, Government Structural Balance ($bn), 2008-2013 182
Figure 54: Economic Indicators, Netherlands, General Government Gross Debt (% of GDP), 2008-2013 183
Figure 55: Economic Indicators, Netherlands, General Government Gross Debt Forecast (% of GDP), 2014-2020 184
Figure 56: Economic Indicators, Netherlands, Major Industries, Output ($bn), 2012 185
Figure 57: Demographics, Netherlands, Population (million), 2008-2013 187
Figure 58: Demographics, Netherlands, Population Forecast (million), 2014-2020 188
Figure 59: Demographics, Netherlands, Population, Urban and Rural Population (%), 2008-2013 189
Figure 60: Demographics, Netherlands, Population, Urban and Rural Population Forecast (%), 2014-2020 190
Figure 61: Demographics, Netherlands, Population Distribution by Age Group (%), 2008-2013 192
Figure 62: Demographics, Netherlands, Population Distribution by Age Group Forecast (%), 2014-2020 193
Figure 63: Demographics, Netherlands, Births (per 1,000 Population), 2008-2013 195
Figure 64: Demographics, Netherlands, Mortality (per 1,000 Population), 2008-2013 196
Figure 65: Demographics, Netherlands, Major Causes of Mortality (‘000), 2012 197
Figure 66: Demographics, Netherlands, Children ?5 Years, Mortality Rate (per 1,000 Live Births), 2008-2013 198
Figure 67: Demographics, Netherlands, Immunization Rate (%), 2008-2013 199
Figure 68: Demographics, Netherlands, Major Causes of Male Mortality (‘000), 2012 200
Figure 69: Demographics, Netherlands, Major Causes of Female Mortality (‘000), 2012 201
Figure 70: Demographics, Netherlands, Gender Ratio (M/F), 2008-2013 203
Figure 71: Demographics, Netherlands, Life Expectancy at Birth (Years), 2008-2013 204
Figure 72: Demographics, Netherlands, Student Enrollment by Level of Education (‘000), 2011 206
Figure 73: Demographics, Netherlands, Unemployment Rate (%), 2008-2013 207
Figure 74: Demographics, Netherlands, Employment by Sector (%), 2012 208
Figure 75: Demographics, Netherlands, Major Causes of Hospitalization (per 10,000 Population), 2011 209
Figure 76: Demographics, Netherlands, Major Diseases, DALYs (per 100,000 Population), 2004 211
Figure 77: Healthcare Infrastructure, Netherlands, Hospitals, 2008-2013 213
Figure 78: Healthcare Infrastructure, Netherlands, Hospital Beds (‘000), 2008-2013 214
Figure 79: Healthcare Infrastructure, Netherlands, Diagnostic Equipment (per 1,000,000 Population), 2008-2013 215
Figure 80: Healthcare Infrastructure, Netherlands, Hospital Beds (per 1,000 Population), 2008-2013 216
Figure 81: Healthcare Infrastructure, Netherlands, Acute Care Hospital Beds (per 1,000 Population), 2008-2013 217
Figure 82: Healthcare Infrastructure, Netherlands, Psychiatric Hospital Beds (per 1,000 Population), 2008-2013 218
Figure 83: Healthcare Infrastructure, Netherlands, Doctors (per 1,000 Population), 2008-2013 219
Figure 84: Healthcare Infrastructure, Netherlands, CO2 Emissions (Billion kg), 2008-2013 221
Figure 85: Healthcare Infrastructure, Netherlands, PM10 Emissions (Million kg), 2008-2013 222
Figure 86: Healthcare Infrastructure, Netherlands, SO2 Emissions (Million kg), 2008-2013 223
Figure 87: Healthcare Infrastructure, Netherlands, Biochemical Oxygen Demand (mg/l), 2008-2013 224
Figure 88: Healthcare Infrastructure, Netherlands, Municipal Waste per Capita (kg), 2008-2013 225
Figure 89: Healthcare Infrastructure, Netherlands, Waste Handling (%), 2012 226
Figure 90: Healthcare Infrastructure, Netherlands, Nurses (per 1,000 Population), 2008-2013 227
Figure 91: Healthcare Infrastructure, Netherlands, Pharmacists (per 1,000 Population), 2008-2013 228
Figure 92: Healthcare Infrastructure, Netherlands, Dentists (per 1,000 Population), 2008-2013 229
Figure 93: Healthcare Expenditure, Netherlands, Healthcare Expenditure (% of GDP), 2008-2013 231
Figure 94: Healthcare Expenditure, Netherlands, Share of Components (%), 2012 232
Figure 95: Healthcare Expenditure, Netherlands, Public-Private Share (%), 2008-2013 233
Figure 96: Healthcare Expenditure, Netherlands, RandD Expenditure by Type of Institution (% of GDP), 2011 234
Figure 97: Healthcare Market, Netherlands, Opportunities and Challenges, 2014 240

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.